HELPDESK ANSWERSDoes rifaximin decrease small intestinal bacterial overgrowth in patients with irritable bowel syndrome?Wright, Kent MD; Middleton, Paul MD; Hudson, Jonell PharmD, BCPS; Coulter, Lois PharmD, BCPS; Vaughn, Brittany MD Author Information UAMS Northwest FMR, Fayetteville, AR The authors declare no conflicts of interest. Evidence-Based Practice 24(11):p 35-36, November 2021. | DOI: 10.1097/EBP.0000000000001333 Buy Metrics Copyright © 2021 by Family Physicians Inquiries Network, Inc.